599 related articles for article (PubMed ID: 33658782)
1. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
[TBL] [Abstract][Full Text] [Related]
2. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
[TBL] [Abstract][Full Text] [Related]
4. Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors.
Fathi M; Abdolahinia ED; Barar J; Omidi Y
Nanomedicine (Lond); 2020 Sep; 15(22):2171-2200. PubMed ID: 32912045
[TBL] [Abstract][Full Text] [Related]
5. Tumor Abnormality-Oriented Nanomedicine Design.
Zhou Q; Xiang J; Qiu N; Wang Y; Piao Y; Shao S; Tang J; Zhou Z; Shen Y
Chem Rev; 2023 Sep; 123(18):10920-10989. PubMed ID: 37713432
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments.
Sun T; Jiang C
Adv Drug Deliv Rev; 2023 May; 196():114773. PubMed ID: 36906230
[TBL] [Abstract][Full Text] [Related]
10. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
11. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
[TBL] [Abstract][Full Text] [Related]
13. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
Peng C; Huang Y; Zheng J
J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.
Zhou L; Wang H; Li Y
Theranostics; 2018; 8(4):1059-1074. PubMed ID: 29463999
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
18. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
[TBL] [Abstract][Full Text] [Related]
19. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.
El-Sawy HS; Al-Abd AM; Ahmed TA; El-Say KM; Torchilin VP
ACS Nano; 2018 Nov; 12(11):10636-10664. PubMed ID: 30335963
[TBL] [Abstract][Full Text] [Related]
20. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]